Nanomedicine News

RSS

New Technique to Form Liposome-Hydrogel Hybrid Nanoscale Vesicles

People have been combining materials to bring forth the best properties of both ever since copper and tin were merged to start the Bronze Age.

From National Institute of Standards and Tech (NIST) 10 Jun 2010

Plastic Antibodies May Fight A Wide Range of Human Diseases

Scientists are reporting the first evidence that a plastic antibody - an artificial version of the proteins produced by the body's immune system to recognize and fight infections and foreign substances - works in the bloodstream of a living animal.

From American Chemical Society 9 Jun 2010

Novel Microfluidic System for Rapid and Sensitive Detection of Rare Circulating Endothelial Progenitor Cells

From sample to answer in just 1 hour with just a finger prick of blood is what researchers from A*STAR Institute of Microelectronics (IME) aim to achieve with their novel microfluidic system for rapid and sensitive detec...

8 Jun 2010

Leonardo Secures Grant to Commercialize Nanoparticle Drug Delivery System

Arrowhead Research Corporation announced today that its portfolio company, Leonardo Biosystems, has received a $2.5 million grant from the Texas Emerging Technology Fund, a state fund established to accelerate commercialization of new technologies.

From Arrowhead Pharmaceutical 8 Jun 2010

Study Shows Nanotechnology PSA Test May Predict Course of Prostate Cancer

Men who have just had their cancerous prostate gland removed have one pressing question for their doctors: Am I cured? But conventional tests haven't been sensitive enough to provide a concrete answer. Current tests...

3 Jun 2010

Researchers Study Anticancer Drug Delivery System Based on Nanosponge Particles

When loaded with an anticancer drug, a delivery system based on a novel material called nanosponge is three to five times more effective at reducing tumor growth than direct injection.

3 Jun 2010

New Supplement for Health Care Features Nano Onion-Like Solid Fullerenes

Nanotechnology has made its way into the health care arena and is now being applied to an important supplement called Nanoxynalpha found at www.nanoxyn.com.

3 Jun 2010

Key Recommendations for Nanomedicine Development in Europe

Experts from key EU projects united in Brussels at Nanomedicine in Europe today to deliver a strong message to the European Parliament that concerted and coordinated action is needed to ensure the widespread benefit...

2 Jun 2010

Anti-Dengue Nanoviricides Proved Effective in Preliminary Studies

NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant efficacy in the recently completed preliminary cell culture studies. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley (UC Berkeley).

From NanoViricides, Inc 1 Jun 2010

Phase 1 CALAA-001 Clinical Trial Shows Systemic siRNA Delivery via Targeted Nanoparticles

Arrowhead Research Corporation today announced that interim data from the phase 1 clinical trial conducted by its majority-owned subsidiary, Calando Pharmaceuticals, will be presented at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting.

From Arrowhead Pharmaceutical 1 Jun 2010